NCT02824536View on ClinicalTrials.gov

3BNC117 and 10-1074 in HIV Uninfected Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 23, 2016

Primary Completion Date

January 9, 2018

Study Completion Date

January 9, 2018

Conditions
Human Immunodeficiency Virus
Interventions
DRUG

3BNC117

Intravenous Infusion of 3BNC117

DRUG

10-1074

Intravenous Infusion of 10-1074

DRUG

Placebo

Intravenous Infusion of Sterile Saline (NaCl 0.9%)

Trial Locations (1)

10065

The Rockefeller University, New York

All Listed Sponsors
lead

Rockefeller University

OTHER

NCT02824536 - 3BNC117 and 10-1074 in HIV Uninfected Adults | Biotech Hunter | Biotech Hunter